Oklahoma Supplier Systems #EV00000959

Oklahoma State Department of Health RFI for Fast-Acting Biosimilar Insulin

This opportunity is a Request for Information (RFI) from the Oklahoma State Department of Health (OSDH) focused on fast-acting biosimilar insulin for the Oklahoma market. - Government Buyer: - Oklahoma State Department of Health (OSDH) - Targeted Respondents: - Pharmaceutical manufacturers of fast-acting biosimilar insulin (no specific OEMs named) - Products/Services Requested: - Fast-acting biosimilar insulin - Information on production capabilities, availability, and pricing - Details on manufacturing locations - Estimated cost savings for Oklahoma residents and payors - Ability to provide matching non-state funds if awarded funding under the Insulin Access and Affordability Program - Unique/Notable Requirements: - Focus on low net cost insulin (excluding rebates except as required by law) - Transparency regarding funding sources - Responses are for informational purposes only and do not obligate the state to purchase - Information may inform future solicitations or contracts

Description

The Oklahoma State Department of Health (OSDH) is seeking input from pharmaceutical manufacturers producing or manufacturing a fast-acting biosimilar insulin. This Request for Information (RFI) aims to gather information regarding the production and availability of low-cost, fast-acting biosimilar insulin in the Oklahoma marketplace. The RFI is issued for informational purposes only and will not be evaluated or obligate the state to any purchase. Responses may be used to prepare future solicitations or contracts related to insulin access and affordability.

View original listing